Sorafenib-Induced Acute Generalized Exanthematous Pustulosis
Open Access
- 29 April 2023
- journal article
- research article
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (2) , e2023130
Abstract
Citation: Cortese A, Pancetti S, Pressiani T, et al. Sorafenib-Induced Acute Generalized Exanthematous Pustulosis. Dermatol Pract Concept. 2023;13(2):e2023130. DOI: https://doi.org/10.5826/dpc.1302a130 Accepted: November 17, 2022; Published: April 2023 Copyright: ©2023 Cortese et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Andrea Cortese, MD, Dermatology, Humanitas Research Hospital – IRCCS, Via A. Manzoni 56, 20089 Rozzano (MI), Italy. E-mail: andreacortese08@gmail.com Keywords : sorafenib, acute generalized exanthematous pustulosis, severe cutaneous adverse reaction, tyrosin-kinase inhibitors This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.Keywords
This publication has 7 references indexed in Scilit:
- Sorafenib-induced Acute Generalized Exanthematous Pustulosis: An Increasing Association?Actas Dermo-Sifiliograficas, 2017
- Acute Generalized Exanthematous Pustulosis Induced by SorafenibJAMA Dermatology, 2014
- Early detection, prevention and management of cutaneous adverse events due to sorafenib: Recommendations from the Sorafenib Working GroupCritical Reviews in Oncology/Hematology, 2012
- Sorafenib-induced acute localized exanthematous pustulosis in a patient with hepatocellular carcinomaBritish Journal of Dermatology, 2011
- Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)British Journal of Dermatology, 2007
- Acute generalized exanthematous pustulosis (AGEP) – A clinical reaction patternJournal of Cutaneous Pathology, 2001
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981